An investigator-initiated phase I/IIa trial of subretinal injection of DVC1-0401 as neuroprotective gene therapy for retinitis pigmentosa
An investigator-initiated phase I/IIa trial of subretinal injection of DVC1-0401 as neuroprotective gene therapy for retinitis pigmentosa - An investigator-initiated trial of DVC1-0401 as gene therapy for retinitis pigmentosa
100 项与 DVC1-0401 相关的专利(医药)